TCI Wealth Advisors, Inc. - HTG MOLECULAR DIAGNOSTICS IN ownership

HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 22 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of HTG MOLECULAR DIAGNOSTICS IN
ValueSharesWeighting
Q3 2020$04000.0%0.00%
Q2 2020$04000.0%0.00%
Q1 2020$04000.0%0.00%
Q4 2019$04000.0%0.00%
Q3 2019$0
-100.0%
4000.0%0.00%
Q2 2019$1,0000.0%4000.0%0.00%
Q1 2019$1,0000.0%4000.0%0.00%
Q4 2018$1,000
-50.0%
4000.0%0.00%
-100.0%
Q3 2018$2,000
+100.0%
4000.0%0.00%
Q2 2018$1,0000.0%4000.0%0.00%
Q1 2018$1,0000.0%4000.0%0.00%
Q4 2017$1,0000.0%4000.0%0.00%
Q3 2017$1,0000.0%4000.0%0.00%
-100.0%
Q2 2017$1,000
-66.7%
4000.0%0.00%
-50.0%
Q1 2017$3,000
+200.0%
4000.0%0.00%
+100.0%
Q4 2016$1,0000.0%400
-20.0%
0.00%0.0%
Q3 2016$1,000500
+400.0%
0.00%
Q2 2016$01000.0%0.00%
Q1 2016$01000.0%0.00%
Q4 2015$0
-100.0%
1000.0%0.00%
-100.0%
Q3 2015$1,0000.0%1000.0%0.00%0.0%
Q2 2015$1,0001000.00%
Other shareholders
HTG MOLECULAR DIAGNOSTICS IN shareholders Q3 2015
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 535,590$2,705,0001.58%
Millrace Asset Group, Inc. 200,000$1,010,0000.79%
Private Wealth Partners, LLC 1,000,000$5,050,0000.77%
PERKINS CAPITAL MANAGEMENT INC 249,700$1,261,0000.76%
Timpani Capital Management LLC 206,119$1,041,0000.30%
Diametric Capital, LP 64,329$325,0000.28%
Granahan Investment Management 941,170$4,753,0000.26%
Kalos Management, Inc. 69,900$308,0000.16%
SYMMETRY PEAK MANAGEMENT LLC 85,000$429,0000.15%
B. Riley Wealth Advisors, Inc. 250,000$1,263,0000.15%
View complete list of HTG MOLECULAR DIAGNOSTICS IN shareholders